Cleared Traditional

K960233 - MINICLINIC OVULATION PREDICTOR

K960233 is an FDA 510(k) clearance for MINICLINIC OVULATION PREDICTOR, manufactured by Vanguard Biomedical Corp.. The device is a Class 1 Chemistry device with product code CEP cleared through the Traditional 510(k) pathway after a 97-day FDA review.

K960233 · Vanguard Biomedical Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1996
Decision
97d
Days
Class 1
Risk

K960233 is an FDA 510(k) clearance for the MINICLINIC OVULATION PREDICTOR. Classified as Radioimmunoassay, Luteinizing Hormone (product code CEP), Class I - General Controls.

Submitted by Vanguard Biomedical Corp. (San Diego, US). The FDA issued a Cleared decision on April 23, 1996 after a review of 97 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1485 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Vanguard Biomedical Corp. devices

FDA 510(k) Submission Details - K960233

510(k) Number K960233 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 17, 1996
Decision Date April 23, 1996
Days to Decision 97 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
9d slower than avg
Panel avg: 88d · This submission: 97d
Pathway characteristics
Predicate-based equivalence.

CEP Device Classification - Class 1, General Controls

Product Code CEP Radioimmunoassay, Luteinizing Hormone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1485
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CEP Radioimmunoassay, Luteinizing Hormone

All 101
Devices cleared under the same product code (CEP) and FDA review panel - the closest regulatory comparables to K960233.
OVUSIGN - ONE-STEP HOME OVULATION PREDICTOR TEST
K963693 · Princeton BioMeditech Corp. · Nov 1996
OPUS HLH
K962866 · Behring Diagnostics, Inc. · Aug 1996
ACS LH2 IMMUNOASSAY
K962041 · Ciba Corning Diagnostics Corp. · Jun 1996
ACTIVE LH IRMA
K961109 · Diagnostic Systems Laboratories, Inc. · Apr 1996
FIRST RESPONSE OVULATION PREDICTOR TEST
K953581 · Armkel, LLC · Oct 1995
CONCEIVE OVULATION PREDICTOR
K953063 · Quidel Corp. · Aug 1995